Mendel is the company behind the clinical AI platform that understands the unstructured, natural language content within medical documents.
Mendel's mission is to build a machine that can learn from the care journey of every patient.
Mendel was founded in 2016 by Karim Galil and Wael Salloum. The company is headquartered in San Jose, California.
Mendel uses novel AI technology to absorb clinical data in medical literature as well as patient health records, to unlock a wide range of Real World Data applications.
Mendel's solution unlocks 80% of the world's clinical data by leveraging contextual understanding to transform unstructured electronic medical record (EMR) data and clinical literature into comprehensive and compliant analytics-ready data.
Mendel abstracts data 27,000 times faster than the primarily manual methods most frequently used in clinical settings, and its output is reviewed and validated by a team of clinical experts to guarantee research-grade output.
Mendel is backed by Oak HC/FT, DCM, Launch Capital, SOSV, OliveTree, Zola Global Investors, Millennium Technology Value Partners, and others. The company raised $40M in Series B round on Apr 21, 2022. This brings Mendel's total funding to $65.4M to date.